Literature DB >> 19474540

The transformation of osteopathic medical education.

Norman Gevitz1.   

Abstract

Osteopathic medical schools and hospital-based postgraduate programs have long constituted small but important sources of physicians and surgeons, particularly for traditionally underserved areas of the United States. Though frequently marginalized in or even left out of standard histories and studies of U.S. medical education, these institutions have become much more difficult to ignore, given the rapid expansion of the number of osteopathic medical students in new and existing colleges and the size of their classes. By 2019, upwards of 25% of all U.S. medical school graduates produced annually will be doctors of osteopathic medicine. The author examines the process through which osteopathy was transformed into osteopathic medicine, how osteopathic medical schools achieved their present status as a significant source of U.S. graduates for residency training, and what challenges osteopathic medical education now faces.

Mesh:

Year:  2009        PMID: 19474540     DOI: 10.1097/ACM.0b013e3181a4049e

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  3 in total

1.  Doctors of osteopathic medicine (DO): a Canadian perspective.

Authors:  Sevan Evren; Andrew Yuzhong Bi; Shuchi Talwar; Andrew Yeh; Howard Teitelbaum
Journal:  Can Med Educ J       Date:  2014-12-17

2.  Introducing Osteopathic Curriculum for Family Medicine Physicians in a Community-based Allopathic Residency Program.

Authors:  Jacob Turnbull; Dan Merck; Karri MacMillan
Journal:  Spartan Med Res J       Date:  2019-07-01

3.  Information Survey on the Use of Complementary and Alternative Medicine.

Authors:  Marco Paoloni; Francesco Agostini; Sergio Bernasconi; Gianni Bona; Carlo Cisari; Massimo Fioranelli; Marco Invernizzi; Antonello Madeo; Marco Matucci-Cerinic; Alberto Migliore; Nicola Quirino; Carlo Ventura; Roberto Viganò; Andrea Bernetti
Journal:  Medicina (Kaunas)       Date:  2022-01-14       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.